Fight Over Waze? Way
Health Care: Drugs
Titan Pharmaceuticals Incorporated (TTNP: OTC)
$0.52 -0.02 | -3.15%
05/24/13 - 03:58 PM ET
468.09K / 1.41M
Vol / Avg. Vol:0.54 / 0.54
Open / Prev. Close:0.52 - 0.54
Today's Range:0.32 - 2.53
52 Wk Range:-50.72%
Performance YTD:TheStreet Rating:
Portfolios with TTNP
- Portfolio NameUser Type
- UserJKE 1
Latest TTNP Headlines from TheStreet
- FDA Rejection of Titan's Probuphine Looks Like a Mugging 05.01.13 | 05:05 am
- Biotech Stock Mailbag: Exact Sciences, Galena, Titan, Arena, Breakthrough Therapy 04.12.13 | 06:04 am
- Titan Pharma: FDA Panel Live Blog 03.21.13 | 07:03 am
- The Next Big Thing In Biotech: Titan
03.14.13 | 12:03 pm - Best And Worst FDA Drug Approval Stocks of 2013 03.12.13 | 08:03 am
- Play TheStreet's FDA Drug Approval Contest 03.05.13 | 12:03 pm
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Titan Pharma: Run-Up Trade Into March FDA Panel 01.31.13 | 06:01 am
Press Releases for TTNP
- Top Stocks On The Move: Medi Swipe Inc., New Western Energy Corp., Titan Pharmaceuticals Inc., And Advanced Cell Technology Inc. - PR Newswire 01.07.13 | 09:01 am
- Titan Reports Fourth Quarter 2010 Fanapt® Royalty - PR Newswire 02.03.11 | 09:02 pm
Partner Headlines for TTNP
